These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35745773)

  • 21. Functional polymeric dialdehyde dextrin network capped mesoporous silica nanoparticles for pH/GSH dual-controlled drug release.
    Chen C; Sun W; Yao W; Wang Y; Ying H; Wang P
    RSC Adv; 2018 Jun; 8(37):20862-20871. PubMed ID: 35542325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.
    Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M
    Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Three-in-One" Multifunctional Gatekeeper Gated Mesoporous Silica Nanoparticles for Intracellular pH-Activated Targeted Cancer Therapy.
    Zhang Y; Wang W; Zhang Y; Cheng M; Wu Q; Yuan Z
    ACS Appl Bio Mater; 2018 Sep; 1(3):572-580. PubMed ID: 34996191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chondroitin sulfate functionalized mesostructured silica nanoparticles as biocompatible carriers for drug delivery.
    Xi J; Qin J; Fan L
    Int J Nanomedicine; 2012; 7():5235-47. PubMed ID: 23091377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
    Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesoporous Silica Nanoprodrug Encapsulated with Near-Infrared Absorption Dye for Photothermal Therapy Combined with Chemotherapy.
    Peng S; Zhang F; Huang B; Wang J; Zhang L
    ACS Appl Bio Mater; 2021 Dec; 4(12):8225-8235. PubMed ID: 35005934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zwitterionic carbon dot-encapsulating pH-responsive mesoporous silica nanoparticles for NIR light-triggered photothermal therapy through pH-controllable release.
    Ryplida B; Lee G; In I; Park SY
    Biomater Sci; 2019 May; 7(6):2600-2610. PubMed ID: 30984942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency.
    Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111239. PubMed ID: 32806268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergetic gating of metal-latching ligands and metal-chelating proteins for mesoporous silica nanovehicles to enhance delivery efficiency.
    Wu S; Deng Q; Huang X; Du X
    ACS Appl Mater Interfaces; 2014 Sep; 6(17):15217-23. PubMed ID: 25137673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
    Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug delivery system with dual imaging and dual response control drug release functions for chemo-photodynamic synergistic therapy.
    Wu ZY; Lee ZH; Huang YY; Tsou MH; Lin HM
    J Inorg Biochem; 2022 May; 230():111717. PubMed ID: 35247856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboxymethyl Cellulose-Grafted Mesoporous Silica Hybrid Nanogels for Enhanced Cellular Uptake and Release of Curcumin.
    Tiwari N; Nawale L; Sarkar D; Badiger MV
    Gels; 2017 Feb; 3(1):. PubMed ID: 30920505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced pH-Responsive Chemo/Chemodynamic Synergistic Cancer Therapy Based on In Situ Cu
    Zhou M; Tian B; Bu Y; Wu Z; Yu J; Wang S; Sun X; Zhu X; Zhou H
    ACS Appl Bio Mater; 2023 Aug; 6(8):3221-3231. PubMed ID: 37428493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
    Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
    Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.
    Choi JY; Ramasamy T; Kim SY; Kim J; Ku SK; Youn YS; Kim JR; Jeong JH; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2016 Jul; 39():94-105. PubMed ID: 27163403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
    Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
    Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.
    Naz S; Wang M; Han Y; Hu B; Teng L; Zhou J; Zhang H; Chen J
    Int J Nanomedicine; 2019; 14():2533-2542. PubMed ID: 31114189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.